Invitrogen™ VEGF-A Cell Lysates Human ELISA Kit

Ref.: BL-RE-092461Manufacturer ref.: EHVEGFACL 96 tests
€712.00 excl. VAT

The Human VEGF-A Cell Lysates ELISA quantitates Hu VEGF-A in human cell or tissue lysates. The assay will exclusively recognize both natural and recombinant Hu VEGF-A. Principle of the method The Human VEGF-A solid-phase sandwich ELISA…

Accession number
P15692
Dose range
8.23-6000 pg/ml
Sensitivity of the dosage
10 pg/ml
Calibration range
10 pg/ml to 6000 pg/ml
Dose
ELISA solid-phase sandwich
Brand
Invitrogen

The Human VEGF-A Cell Lysates ELISA quantitates Hu VEGF-A in human cell or tissue lysates. The assay will exclusively recognize both natural and recombinant Hu VEGF-A. Principle of the method The Human VEGF-A solid-phase sandwich ELISA…

The Human VEGF-A Cell Lysates ELISA quantitates Hu VEGF-A in human cell or tissue lysates. The assay will exclusively recognize both natural and recombinant Hu VEGF-A. Principle of the method The Human VEGF-A solid-phase sandwich ELISA (enzyme-linked immunosorbent assay) is designed to measure the amount of the target bound between a matched antibody pair. A target-specific antibody has been pre-coated in the wells of the supplied microplate. Samples, standards, or controls are then added into these wells and bind to the immobilized (capture) antibody. The sandwich is formed by the addition of the second (detector) antibody, a substrate solution is added that reacts with the enzyme-antibody-target complex to produce measurable signal. The intensity of this signal is directly proportional to the concentration of target present in the original specimen. Rigorous validation Each manufactured lot of this ELISA kit is quality tested for criteria such as sensitivity, specificity, precision, and lot-to-lot consistency. See manual for more information on validation.

VEGF (vascular endothelial growth factor), which is a homodimer glycoprotein with disulfide bridges involved in 45 kDa angiogenesis, promotes tumour progression and metastases. VEGF has various effects on vascular endothelium, including the ability to promote endothelial cell viability, mitogenesis, chemotaxia and vascular permeability. VEGF's family currently includes VEGF-A, VEGF-B, VEGF-C, VEGF-D, VEGF-E and PIGF. The VEGF and its receptor system have proven to be the fundamental regulators of cell signaling of langenogenicity. Most tumours have the absolute requirement of angiogenesis and VEGF has been described as the most potent angiogenic cytokine associated with this process. To date, 5 different VEGF isoforms have been described. These isoforms are generated following an alternative splicing from a single VEGF gene. These isoforms bind to two tyrosine-kinase flt-1 (VEGFR-1) and flk-1/KDR (VEGFR-2) receptors, which express almost exclusively on endothelial cells. VEGF and its high affinity binding receptors, tyrosine kinases FLK1 and FLT1, would be important for the development of the embryonic vascular system. Studies have shown that an alternately spliced form of FLT1 produces a soluble protein, called sFLT1, which binds vascular endothelial growth factor with high affinity, acting as an inhibitor in angiogenesis. High levels of VEGF are associated with POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammapathy, skin changes), also known as Crow-Fukase syndrome, which affects several organs of the body.

Sensitivity

Sensitivity of dosage: 10 pg/ml.

Measurement range

Dose range: 8.23-6000 pg/ml.

Duration of dosing

Total duration of dosing: 4 h 45 min.

Reproducibility

Intradose variation coefficient < 10%, interdose < 12%.

Specificity

The antibody pair provided in this kit recognizes the human VEGF-A.

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)15445173
Specifications
Accession numberP15692
Dose range8.23-6000 pg/ml
Sensitivity of the dosage10 pg/ml
Calibration range10 pg/ml to 6000 pg/ml
DoseELISA solid-phase sandwich
ConjugateBiotin
Product typeKit ELISA
Protein familyChemiokine & receptors
Type of sampleCellular lysates
SpecificityThe antibody pair provided in this kit recognizes the human VEGF-A.
Sufficient for96 dosages
Target speciesHuman
For use with (application)ELISA, protein dosage, protein biology, cancerology, immunology, neuroscience, neurobiology, protein detection, protein analyses
For use with (equipment)Colorimetric microplate reader
Genetic identification (Enter)7422
Gene symbol(s)MVCD1,VEGF,VPF
Coefficient of inter-dose variation< 12 %
Coefficient of intra-dose variation< 10 %
Contents of kits96-well pre-coated plate, Standard, Dose diluent concentrate, Biotinylated detection antibody, Wash pad, Chromogen, Stop solution, Adhesive plate covers, Adhesive plate covers
Marker or dyeHRP
Quantity96 tests
Regulatory statusRUO
Research disciplinesImmunology
SynonymRP1-261G23.1, MVCD1, VEGF, VPF
TargetHuman
Test time1 h 20 min
Physical characteristics
Volume of sampleCell Lysate (.50 μl)
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing4 h 45 min

Origin and customs

Manufacturer ref.EHVEGFACL
Country of originUnited States
HS customs code3002 15 00 00
A question or a specific configuration?
Contact us for a quote.